BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 34151536)

  • 1. Analysis of high-risk pedigrees identifies 11 candidate variants for Alzheimer's disease.
    Teerlink CC; Miller JB; Vance EL; Staley LA; Stevens J; Tavana JP; Cloward ME; Page ML; Dayton L; ; Cannon-Albright LA; Kauwe JSK
    Alzheimers Dement; 2022 Feb; 18(2):307-317. PubMed ID: 34151536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and genomic analysis of pedigrees with exceptional longevity identifies candidate rare variants.
    Miller JB; Ward E; Staley LA; Stevens J; Teerlink CC; Tavana JP; Cloward M; Page M; Dayton L; ; Cannon-Albright LA; Kauwe JSK
    Neurobiol Dis; 2020 Sep; 143():104972. PubMed ID: 32574725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A likely HOXC4 predisposition variant for Chiari malformations.
    Brockmeyer DL; Cheshier SH; Stevens J; Facelli JC; Rowe K; Heiss JD; Musolf A; Viskochil DH; Allen-Brady KL; Cannon-Albright LA
    J Neurosurg; 2023 Jul; 139(1):266-274. PubMed ID: 36433874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted sequencing of ABCA7 identifies splicing, stop-gain and intronic risk variants for Alzheimer disease.
    Kunkle BW; Carney RM; Kohli MA; Naj AC; Hamilton-Nelson KL; Whitehead PL; Wang L; Lang R; Cuccaro ML; Vance JM; Byrd GS; Beecham GW; Gilbert JR; Martin ER; Haines JL; Pericak-Vance MA
    Neurosci Lett; 2017 May; 649():124-129. PubMed ID: 28400126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABCA7 p.G215S as potential protective factor for Alzheimer's disease.
    Sassi C; Nalls MA; Ridge PG; Gibbs JR; Ding J; Lupton MK; Troakes C; Lunnon K; Al-Sarraj S; Brown KS; Medway C; Clement N; Lord J; Turton J; Bras J; Almeida MR; ; Holstege H; Louwersheimer E; van der Flier WM; Scheltens P; Van Swieten JC; Santana I; Oliveira C; Morgan K; Powell JF; Kauwe JS; Cruchaga C; Goate AM; Singleton AB; Guerreiro R; Hardy J
    Neurobiol Aging; 2016 Oct; 46():235.e1-9. PubMed ID: 27289440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution to Alzheimer's disease risk of rare variants in TREM2, SORL1, and ABCA7 in 1779 cases and 1273 controls.
    Bellenguez C; Charbonnier C; Grenier-Boley B; Quenez O; Le Guennec K; Nicolas G; Chauhan G; Wallon D; Rousseau S; Richard AC; Boland A; Bourque G; Munter HM; Olaso R; Meyer V; Rollin-Sillaire A; Pasquier F; Letenneur L; Redon R; Dartigues JF; Tzourio C; Frebourg T; Lathrop M; Deleuze JF; Hannequin D; Genin E; Amouyel P; Debette S; Lambert JC; Campion D;
    Neurobiol Aging; 2017 Nov; 59():220.e1-220.e9. PubMed ID: 28789839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of ABCA7 in Alzheimer's disease: evidence from genomics, transcriptomics and methylomics.
    De Roeck A; Van Broeckhoven C; Sleegers K
    Acta Neuropathol; 2019 Aug; 138(2):201-220. PubMed ID: 30903345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenge accepted: uncovering the role of rare genetic variants in Alzheimer's disease.
    Khani M; Gibbons E; Bras J; Guerreiro R
    Mol Neurodegener; 2022 Jan; 17(1):3. PubMed ID: 35000612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of ABCA7 loss-of-function variant in Alzheimer's disease: a replication study in European-Americans.
    Del-Aguila JL; Fernández MV; Jimenez J; Black K; Ma S; Deming Y; Carrell D; Saef B; ; Howells B; Budde J; Cruchaga C
    Alzheimers Res Ther; 2015 Dec; 7(1):73. PubMed ID: 26654793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rare FGF5 candidate variant (rs112475347) for predisposition to nonsquamous, nonsmall-cell lung cancer.
    Cannon-Albright LA; Teerlink CC; Stevens J; Facelli JC; Carr SR; Allen-Brady K; Puri S; Bailey-Wilson JE; Musolf AM; ; Akerley W
    Int J Cancer; 2023 Jul; 153(2):364-372. PubMed ID: 36916144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-exome sequencing of the BDR cohort: evidence to support the role of the PILRA gene in Alzheimer's disease.
    Patel T; Brookes KJ; Turton J; Chaudhury S; Guetta-Baranes T; Guerreiro R; Bras J; Hernandez D; Singleton A; Francis PT; Hardy J; Morgan K
    Neuropathol Appl Neurobiol; 2018 Aug; 44(5):506-521. PubMed ID: 29181857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deleterious ABCA7 mutations and transcript rescue mechanisms in early onset Alzheimer's disease.
    De Roeck A; Van den Bossche T; van der Zee J; Verheijen J; De Coster W; Van Dongen J; Dillen L; Baradaran-Heravi Y; Heeman B; Sanchez-Valle R; Lladó A; Nacmias B; Sorbi S; Gelpi E; Grau-Rivera O; Gómez-Tortosa E; Pastor P; Ortega-Cubero S; Pastor MA; Graff C; Thonberg H; Benussi L; Ghidoni R; Binetti G; de Mendonça A; Martins M; Borroni B; Padovani A; Almeida MR; Santana I; Diehl-Schmid J; Alexopoulos P; Clarimon J; Lleó A; Fortea J; Tsolaki M; Koutroumani M; Matěj R; Rohan Z; De Deyn P; Engelborghs S; Cras P; Van Broeckhoven C; Sleegers K;
    Acta Neuropathol; 2017 Sep; 134(3):475-487. PubMed ID: 28447221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strong evidence for a genetic contribution to late-onset Alzheimer's disease mortality: a population-based study.
    Kauwe JS; Ridge PG; Foster NL; Cannon-Albright LA
    PLoS One; 2013; 8(10):e77087. PubMed ID: 24116205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SORL1 genetic variants and Alzheimer disease risk: a literature review and meta-analysis of sequencing data.
    Campion D; Charbonnier C; Nicolas G
    Acta Neuropathol; 2019 Aug; 138(2):173-186. PubMed ID: 30911827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABCA7 Genotypes Confer Alzheimer's Disease Risk by Modulating Amyloid-β Pathology.
    Zhao QF; Wan Y; Wang HF; Sun FR; Hao XK; Tan MS; Tan CC; Zhang DQ; Tan L; Yu JT;
    J Alzheimers Dis; 2016 Mar; 52(2):693-703. PubMed ID: 27003212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in ABCA7 in a Belgian cohort of Alzheimer's disease patients: a targeted resequencing study.
    Cuyvers E; De Roeck A; Van den Bossche T; Van Cauwenberghe C; Bettens K; Vermeulen S; Mattheijssens M; Peeters K; Engelborghs S; Vandenbulcke M; Vandenberghe R; De Deyn PP; Van Broeckhoven C; Sleegers K
    Lancet Neurol; 2015 Aug; 14(8):814-822. PubMed ID: 26141617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association study of the ABCA7 rs3752246 polymorphism in Alzheimer's disease.
    Fehér Á; Juhász A; Pákáski M; Janka Z; Kálmán J
    Psychiatry Res; 2019 Sep; 279():376-377. PubMed ID: 30717989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-Analysis of the Association between Variants in ABCA7 and Alzheimer's Disease.
    Ma FC; Wang HF; Cao XP; Tan CC; Tan L; Yu JT
    J Alzheimers Dis; 2018; 63(4):1261-1267. PubMed ID: 29782324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rare missense mutations in ABCA7 might increase Alzheimer's disease risk by plasma membrane exclusion.
    Bossaerts L; Hendrickx Van de Craen E; Cacace R; Asselbergh B; Van Broeckhoven C
    Acta Neuropathol Commun; 2022 Mar; 10(1):43. PubMed ID: 35361255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABCA7 rare variants and Alzheimer disease risk.
    Le Guennec K; Nicolas G; Quenez O; Charbonnier C; Wallon D; Bellenguez C; Grenier-Boley B; Rousseau S; Richard AC; Rovelet-Lecrux A; Bacq D; Garnier JG; Olaso R; Boland A; Meyer V; Deleuze JF; Amouyel P; Munter HM; Bourque G; Lathrop M; Frebourg T; Redon R; Letenneur L; Dartigues JF; Pasquier F; Rollin-Sillaire A; Génin E; Lambert JC; Hannequin D; Campion D;
    Neurology; 2016 Jun; 86(23):2134-7. PubMed ID: 27037229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.